British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer Immuno ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed last ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Teva Pharmaceutical Industries Ltd. ADR 0.46% $24.53B ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

At close: January 23 at 4:00:02 PM EST ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

After hours: January 24 at 7:46:59 p.m. EST ...

German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 28, 2025. REUTERS/Staff/File Photo World markets were suddenly looking calmer on Wednesday as ...